RS

Rajendra Sitaram Bhat

Director DIN 07973575
DIN 07973575 First appointment Nov 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajendra Sitaram Bhat

Data last updated:

Rajendra Sitaram Bhat was a Director at Think Big Mining Private Limited (from 2017) and Director at Rbsd Medifast Pharma Private Limited (from 2019).

DIN 07973575
First Appointment 17 Nov 2017
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Think Big Mining Private Limited U14299KA2017PTC107976
Director17 Nov 20172017Strike Off
Rbsd Medifast Pharma Private Limited U74999PN2019PTC182134
Director12 Feb 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Think Big Mining Private Limited
Rbsd Medifast Pharma Private Limited
Premium access

Shareholding and investment profile for Rajendra Sitaram Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Sitaram Bhat

Rajendra Sitaram Bhat was first appointed on 17 Nov 2017 as Director at Think Big Mining Private Limited. The most recent appointment on record is 12 Feb 2019 at Rbsd Medifast Pharma Private Limited.

Rajendra Sitaram Bhat held 2 earlier board appointments: Think Big Mining Private Limited (Director, from 17 Nov 2017); Rbsd Medifast Pharma Private Limited (Director, from 12 Feb 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available